Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Innovex International, Inc.DRQ · Entity 4462 | VP - Finance and CFO | November 16, 2016 | November 18, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Innovex International, Inc.
Report date November 16, 2016 · Filed November 18, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,085 |
Ending reported balance
After 2016-11-16 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2016-11-16 · Exercise / conversion · Acquired 10,000 · Balance 43,085 Row 2 · 2016-11-16 · Sale · Disposed 10,000 · Balance 33,085 F1: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.00 to $53.25 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $20.98 · Expires 2018-10-28 | Direct | 0 |
Reported balance
After 2016-11-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-11-16 · Exercise / conversion · Disposed 10,000 · Balance 0 F2: The stock options became exercisable in increments on the first, second, third and fourth anniversaries of the grant. The grant date was October 28, 2008. |
Filing footnotes · ownership attribution and instrument terms
F1: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.00 to $53.25 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F2: The stock options became exercisable in increments on the first, second, third and fourth anniversaries of the grant. The grant date was October 28, 2008.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 16, 2016 Filed Nov 18, 2016 21:05 UTC | Innovex International, Inc. DRQ · Entity 4462 | Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $20.98 | $0.00 |
DisclosureSEC source: 0001562180-16-003579 · primarydocument.xml · derivative · entry 3 BROOKS JERRY M · CIK 0001240970 · VP - Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2018-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options became exercisable in increments on the first, second, third and fourth anniversaries of the grant. The grant date was October 28, 2008. Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 21:05 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 10,000 | $53.11 | $531,100.00 |
DisclosureSEC source: 0001562180-16-003579 · primarydocument.xml · nonDerivative · entry 2 BROOKS JERRY M · CIK 0001240970 · VP - Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,085 F1 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.00 to $53.25 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 21:05 UTC | Innovex International, Inc. DRQ · Entity 4462 | Exercise / conversionCommon Stock | 10,000 | $20.98 | $209,800.00 |
DisclosureSEC source: 0001562180-16-003579 · primarydocument.xml · nonDerivative · entry 1 BROOKS JERRY M · CIK 0001240970 · VP - Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,085 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 21:04 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 3,169 | $47.59 | $150,812.71 |
DisclosureSEC source: 0001562180-16-003327 · primarydocument.xml · nonDerivative · entry 3 BROOKS JERRY M · CIK 0001240970 · VP - Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,085 F2 · kind: Sale to cover tax obligations of vested restricted stock and performance unit awards pursuant to a 10b5-1 plan adopted on May 16, 2013. F3 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.45 to $47.8583 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| October 28, 2016 Filed Nov 1, 2016 21:04 UTC | Innovex International, Inc. DRQ · Entity 4462 | GrantCommon Stock | 3,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-16-003327 · primarydocument.xml · nonDerivative · entry 2 BROOKS JERRY M · CIK 0001240970 · VP - Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,254 F1 · shares: These shares vested pursuant to the terms of performance unit awards granted on October 26, 2013. Read SEC document |
| October 28, 2016 Filed Nov 1, 2016 21:04 UTC | Innovex International, Inc. DRQ · Entity 4462 | GrantCommon Stock | 8,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-16-003327 · primarydocument.xml · nonDerivative · entry 1 BROOKS JERRY M · CIK 0001240970 · VP - Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,044 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.